Rankings
▼
Calendar
RYTM Q1 2016 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RYTM
Rhythm Pharmaceuticals, Inc.
$6B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$6M
EPS (Diluted)
$-0.61
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$282,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$32M
Cash & Equivalents
-$35M
← FY 2016
All Quarters
Q2 2016 →
